Clinical Trial Update: Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults With Primary Open Angle Glaucoma or Ocular Hypertension [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial comparing BL1107 eye drops to timolol for primary open-angle glaucoma or ocular hypertension, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• BL1107 Eye Drops (BL1107)
• Timolol (timolol)

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Glaucoma | Phase 2 | Status: RECRUITING